Revenue

An Innventure company proves its technology can turn real-world plastic trash into valuable chemicals, but can it navigate the path to commercialization?

T3 Defense acquires a majority stake in a key Israeli manufacturer, a strategic move to ease production bottlenecks and strengthen the defense industrial base.

Partnering with Stripe's Bridge, Payoneer is embedding stablecoin payments to simplify cross-border trade for its nearly 2 million business customers.

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Watchmaker Genomics is repurposing CRISPR, not for editing genes, but to make DNA sequencing faster, cheaper, and more reliable than ever before.

As deepfakes and synthetic identities surge, Aware, Inc. earns critical third-party certifications, proving its tech is secure, fair, and ready for reality.

ASCU pays millions to end its partnership with a Rio Tinto venture, betting it can develop the massive Cactus copper project in Arizona all on its own.

Tampa's The Cake Girl marks 10 years of success. Founder Kristina Lavallee's journey from a food truck to a national dessert authority is a masterclass in grit.

LiveRamp adds Uber's ad chief and retail media architect Kristi Argyilan to its board, signaling a major push into the future of AI-driven commerce media.

A new oral drug from Nimbus Therapeutics uses AI-driven precision to fight inflammation and repair tissue, offering new hope for millions with IBD.

An OTC-listed company's $11.7M deal for a Texas power plant highlights a critical trend: the race to secure private energy for the AI revolution.

Palo Alto Networks acquires Koi for a reported $400M, aiming to secure the new 'Agentic Endpoint' and define the next era of enterprise AI security.

Online casino Betty expands its Toronto footprint with new TFC and Argos partnerships, navigating a market defined by rapid growth and strict regulations.

Nakamoto Inc. acquires Bitcoin Magazine's parent and a key investment firm in an all-stock deal, raising questions about market influence and shareholder value.

Cyrano Therapeutics' CYR-064 shows promise in a Phase 2 study, potentially becoming the first approved drug for persistent post-viral smell loss.

With demand for freeze-drying surging, OFD adds project management veteran Danielle Grosso to its expanding leadership team to scale operations.

As Revvity execs prepare for key conferences, investors will watch for clues on AI strategy, growth guidance, and margin recovery after a mixed 2025.

In a crowded market, JETOUR is ditching spec-sheet wars for storytelling, launching a global film series to redefine its brand as a companion for life's journeys.

An independent board again backs the safety of BriaCell's metastatic breast cancer therapy in a pivotal Phase 3 trial, boosting hope for a new treatment.

Provident Bank hires industry veteran Joseph A. Tammaro, Jr. to head its Middle Market Lending, signaling a strategic move to capture regional market share.